BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/6/2022 8:50:05 AM | Browse: 678 | Download: 1630
 |
Received |
|
2021-11-09 04:06 |
|
Peer-Review Started |
|
2021-11-09 04:08 |
|
First Decision by Editorial Office Director |
|
2022-01-09 08:25 |
|
Return for Revision |
|
2022-01-09 08:25 |
|
Revised |
|
2022-01-22 04:25 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2022-03-04 05:58 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2022-03-06 22:53 |
|
Articles in Press |
|
2022-03-06 22:53 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-03-30 07:59 |
|
Publish the Manuscript Online |
|
2022-04-06 08:50 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Radiomics signature: A potential biomarker for β-arrestin1 phosphorylation prediction in hepatocellular carcinoma
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Feng Che, Qing Xu, Qian Li, Zi-Xing Huang, Cai-Wei Yang, Li-Ye Wang, Yi Wei, Yu-Jun Shi and Bin Song |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
81971571 |
| Science and Technology Support Program of Sichuan Province |
2021YFS0144 |
| Science and Technology Support Program of Sichuan Province |
2021YFS0021 |
| China Postdoctoral Science Foundation |
2021M692289 |
|
| Corresponding Author |
Bin Song, MD, Chief Doctor, Doctor, Doctor, Professor, Department of Radiology, West China Hospital, Sichuan University, No 37, GUOXUE Alley, Wuhou district, Chengdu 610041, Sichuan Province, China. songlab_radiology@163.com |
| Key Words |
Hepatocellular carcinoma; Sorafenib resistance; β-Arrestin1 phosphorylation; Radiomics; Computed tomography; Overall survival |
| Core Tip |
The aim of this study was to develop and validate radiomics-based models for predicting β-arrestin1 phosphorylation in hepatocellular carcinoma (HCC). A total of 99 HCC patients (training cohort: n = 69; validation cohort: n = 30) were included, and the final clinico-radiological-radiomics model integrating the radiomics scores and clinico-radiological risk factors showed satisfactory discriminative performance (AUC = 0.898, 95%CI, 0.820 to 0.977). The preoperative prediction model can be used as a noninvasive and effective tool to help predict the outcome of HCC patients treated with sorafenib and identify patients who would benefit most from sorafenib treatment. |
| Publish Date |
2022-04-06 08:50 |
| Citation |
Che F, Xu Q, Li Q, Huang ZX, Yang CW, Wang LY, Wei Y, Shi YJ, Song B. Radiomics signature: A potential biomarker for β-arrestin1 phosphorylation prediction in hepatocellular carcinoma. World J Gastroenterol 2022; 28(14): 1479-1493 |
| URL |
https://www.wjgnet.com/1007-9327/full/v28/i14/1479.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v28.i14.1479 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
